All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @d5health on TikTok · 118s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @d5health's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Happy Sunday everybody, Dr. Philip Dival here, and I'm going to talk about testosterone.
  2. 0:05If you're a male, you should know what your testosterone level is, and it should be checked
  3. 0:09annually.
  4. 0:10In fact, even at a young age, I think it's great to get a baseline, because there is an epidemic
  5. 0:16going on of low testosterone levels.
  6. 0:19Maybe tied to lowering fertility rates.
  7. 0:21There's a lot of factors, mostly lifestyle, probably environmental toxins, but lab core and
  8. 0:27requests have shifted the normal range to fit sick America.
  9. 0:3150 years ago, say 500 to 1100 may have been normal.
  10. 0:36Now, you can be normal under 300.
  11. 0:40That is not normal.
  12. 0:41And frankly, I don't think that's the way to live.
  13. 0:44So, low testosterone, newer studies have shown increased risk of prostate cancer over time,
  14. 0:51short-term, lower vitality, poor mood, lower libido, lower cognitive function, low muscle
  15. 0:58mass, long-term poor bone health, metabolic risks, insulin resistance, abnormal cholesterol.
  16. 1:07There are a lot of reasons to have your levels checked, and have a thorough discussion on
  17. 1:12the pros and cons of replacement therapy.
  18. 1:15But if you're a male, whether you're going through andropause, which is kind of a menopause
  19. 1:21for men, or if you're having symptoms of low testosterone, just can't seem to recover very
  20. 1:27well.
  21. 1:28I'm having a hard time making gains in the gym, your moods off, feeling cranky, having fatigue,
  22. 1:36you should have your testosterone levels checked.
  23. 1:38Females too, but I'm going to focus on males for this post.
  24. 1:41So, as I've been testing a lot of people, I am not finding normal levels, okay?
  25. 1:47So, that's not just me.
  26. 1:49So if that resonates with you at all, then give me a call, let's run a panel, and see
  27. 1:55where you are.
  28. 1:56You'll thank me.
  29. 1:57Bye.

Dr. Deibel's testosterone claims need some context

Dr. Philip Deibel

TikTok creator

8.0K viewsWatch on TikTok

Quick answer

Hypogonadism is clinically defined as persistently low serum testosterone combined with signs and symptoms of deficiency, not lab values alone. The Endocrine Society recommends against population-wide testosterone screening in asymptomatic men, while acknowledging that symptomatic men with confirmed low levels may benefit from TRT after a thorough risk-benefit discussion. Prostate cancer risk in the context of TRT remains an active area of research, and current guidelines do not support the claim that low testosterone definitively increases prostate cancer risk.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Dr. Deibel's testosterone claims need some context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Dr. Deibel's testosterone claims need some context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Dr. Deibel's testosterone claims need some context" from Dr. Philip Deibel. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Hypogonadism is clinically defined as persistently low serum testosterone combined with signs and symptoms of deficiency, not lab values alone.

The reason this review is not generic is the source wording and the canonical claim label "trt day 33 the low testosterone epidemic if you are a male the." In this clip, the useful excerpt is: "Happy Sunday everybody, Dr." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Travison et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Hypogonadism is clinically defined as persistently low serum testosterone combined with signs and symptoms of deficiency, not lab values alone.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Hypogonadism is clinically defined as persistently low serum testosterone combined with signs and symptoms of deficiency, not lab values alone. The Endocrine Society recommends against population-wide testosterone screening in asymptomatic men, while acknowledging that symptomatic men with confirmed low levels may benefit from TRT after a thorough risk-benefit discussion. Prostate cancer risk in the context of TRT remains an active area of research, and current guidelines do not support the claim that low testosterone definitively increases prostate cancer risk.
  • The Endocrine Society does not recommend routine testosterone screening in asymptomatic men. Testing is appropriate when symptoms such as low libido, fatigue, or poor recovery are present.
  • Travison et al. (2007, JCEM) confirmed that average testosterone levels in American men have declined over several decades, independent of age, lending credibility to the broader trend the creator describes.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The Endocrine Society does not recommend routine testosterone screening in asymptomatic men. Testing is appropriate when symptoms such as low libido, fatigue, or poor recovery are present.
  • Travison et al. (2007, JCEM) confirmed that average testosterone levels in American men have declined over several decades, independent of age, lending credibility to the broader trend the creator describes.
  • The clinical threshold of 300 ng/dL for hypogonadism comes from Endocrine Society and AUA clinical guidelines, not arbitrary lab policy. Reference ranges and diagnostic thresholds are different tools.
  • The Testosterone Trials (Snyder et al., 2016, NEJM) showed TRT improved mood, sexual function, and bone density in symptomatic older men, but also raised signals for cardiovascular and hematologic risk that warrant monitoring.
  • TRT suppresses the hypothalamic-pituitary-gonadal axis, which can cause fertility impairment and testicular atrophy. Men considering TRT who want to preserve fertility should discuss alternatives such as clomiphene or hCG with a urologist.
  • A full diagnostic workup should include free testosterone, SHBG, LH, FSH, complete blood count, and metabolic panel, not total testosterone alone, before any treatment decision is made.
  • The prostate cancer association with low testosterone is an emerging area of research but causality is unproven. Current guidelines do not list low testosterone as a confirmed prostate cancer risk factor.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @d5health actually say?

Dr. Philip Dival argues that low testosterone is a widespread epidemic driven by lifestyle and environmental toxins. His most pointed claim: LabCorp and Quest Diagnostics have deliberately shifted the normal testosterone range downward to accommodate an already unhealthy male population, so that a reading below 300 ng/dL can now be called "normal" when it historically would not have been. He also lists low T as a risk factor for prostate cancer, metabolic syndrome, insulin resistance, and cognitive decline, and recommends annual testing starting at a young age.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Philip Deibel · TikTok creator

8.0K views on this video

Day 33. The low testosterone epidemic. If you are a male then you should know your testosterone level, and have it checked annually. Labs are shifting the normal range lower in order to fit sick Ameri

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the endocrine society does not recommend routine testosterone screening in?

The Endocrine Society does not recommend routine testosterone screening in asymptomatic men. Testing is appropriate when symptoms such as low libido, fatigue, or poor recovery are present.

What does the video say about travison et al. (2007, jcem) confirmed?

Travison et al. (2007, JCEM) confirmed that average testosterone levels in American men have declined over several decades, independent of age, lending credibility to the broader trend the creator describes.

What does the video say about the clinical threshold of 300 ng/dl for hypogonadism comes from?

The clinical threshold of 300 ng/dL for hypogonadism comes from Endocrine Society and AUA clinical guidelines, not arbitrary lab policy. Reference ranges and diagnostic thresholds are different tools.

What does the video say about the testosterone trials (snyder et al., 2016, nejm) showed trt?

The Testosterone Trials (Snyder et al., 2016, NEJM) showed TRT improved mood, sexual function, and bone density in symptomatic older men, but also raised signals for cardiovascular and hematologic risk that warrant monitoring.

What does the video say about trt suppresses the hypothalamic-pituitary-gonadal axis,?

TRT suppresses the hypothalamic-pituitary-gonadal axis, which can cause fertility impairment and testicular atrophy. Men considering TRT who want to preserve fertility should discuss alternatives such as clomiphene or hCG with a urologist.

What does the video say about a full diagnostic workup should include free testosterone, shbg, lh,?

A full diagnostic workup should include free testosterone, SHBG, LH, FSH, complete blood count, and metabolic panel, not total testosterone alone, before any treatment decision is made.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Philip Deibel, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.